← Back to Search

Behavioral Intervention

Intervention Group for Depression

N/A
Waitlist Available
Led By Orion Mowbray, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial aims to assess if a kind of psychotherapy called SFBT is effective for treating depression in primary care settings. It will also look if it can reduce health markers like blood pressure and A1C.

Eligible Conditions
  • Depression
  • Diabetes
  • High Blood Pressure
  • Anxiety Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability measure
Depression outcomes
Diabetes Outcomes
+2 more
Secondary outcome measures
Hypertension

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment2 Interventions
The intervention group will receive 3 sessions of SFBT from a licensed therapist in addition to treatment as usual
Group II: ControlActive Control1 Intervention
This group will be the treatment as usual group who will receive primary care treatment without the SFBT intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Solution Focused Intervention
2023
N/A
~80

Find a Location

Who is running the clinical trial?

University of GeorgiaLead Sponsor
100 Previous Clinical Trials
34,578 Total Patients Enrolled
3 Trials studying Depression
802 Patients Enrolled for Depression
Orion Mowbray, PhDPrincipal InvestigatorUniversity of Georgia

Media Library

Solution Focused Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05838222 — N/A
Depression Research Study Groups: Control, Intervention Group
Depression Clinical Trial 2023: Solution Focused Intervention Highlights & Side Effects. Trial Name: NCT05838222 — N/A
Solution Focused Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838222 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this experiment open to new participants?

"Per the information on clinicaltrials.gov, this particular medical trial is not accepting patients at present. The initial posting was made on May 1st 2023 and recently revised on April 20th of the same year. Although participation in this study has been suspended, there are still 3365 other research projects actively seeking enrolment from potential participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Integrating Solution Focused Interventions in Integrated Care
Orion Mowbray 2023. "Integrating Solution Focused Interventions in Integrated Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05838222.
~42 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top